Full Text
<article class="scholarly-article">
<h2>Introduction</h2>
<p>Long non-coding RNAs (lncRNAs) are defined as transcripts exceeding 200 nucleotides in length with limited or no protein-coding potential. Over the past two decades, lncRNAs have been recognized as key regulators of gene expression, acting through diverse mechanisms including transcriptional interference, post-transcriptional modulation, and chromatin remodeling [1,4]. Among these, the ability of lncRNAs to serve as molecular scaffolds that recruit chromatin-modifying complexes to specific genomic loci has garnered particular attention [13,26]. This scaffolding function enables the precise deposition of histone marks and DNA methylation patterns, leading to stable gene silencing [30].</p><p>The archetypal example of lncRNA-mediated gene silencing is X-chromosome inactivation in mammals, orchestrated by the lncRNA Xist. Xist spreads along the X chromosome and recruits polycomb repressive complex 2 (PRC2), which catalyzes the trimethylation of histone H3 at lysine 27 (H3K27me3), a hallmark of facultative heterochromatin [30]. Subsequent studies have revealed that many other lncRNAs, including HOTAIR, MEG3, and ANRIL, similarly recruit chromatin modifiers to silence gene expression in development and disease [7,16,24]. The scaffold model posits that lncRNAs provide a platform for the assembly of multiple protein complexes, thereby coordinating enzymatic activities and targeting specificity [1,26].</p><p>Despite significant progress, the molecular details of lncRNA–chromatin modifier interactions remain incompletely understood. Questions persist regarding the structural features that confer scaffold capacity, the stoichiometry of recruited complexes, and the dynamics of recruitment during cellular differentiation [13,17]. Furthermore, the extent to which lncRNA scaffolds are utilized across the genome and the degree of functional redundancy among different lncRNAs are active areas of investigation [2,4].</p><p>In this article, we provide a comprehensive review of lncRNAs that function as scaffolds for chromatin modifier recruitment in gene silencing. We examine the experimental evidence supporting this model, discuss the structural and biochemical determinants of scaffold activity, and synthesize data from recent genome-wide studies. Using a meta-analytical approach, we quantify the repertoire of lncRNAs with validated scaffolding functions and characterize their interaction networks. Our findings underscore the central role of lncRNA scaffolds in epigenetic regulation and open new avenues for therapeutic intervention in diseases with aberrant gene silencing.</p>
<h2>Literature Review</h2>
<p>The concept of lncRNAs as scaffolds for chromatin modifiers emerged from studies of Xist and other lncRNAs involved in imprinting and dosage compensation [30]. Early work demonstrated that Xist binds PRC2 directly and is required for its localization to the inactive X chromosome [13]. Subsequent biochemical analyses identified specific repeat domains within Xist that mediate PRC2 recruitment [1,4]. Similarly, the lncRNA HOTAIR, transcribed from the HOXC locus, was shown to bind both PRC2 and the LSD1/CoREST/REST complex, thereby coordinating histone methylation and demethylation to silence HOXD genes [7,26].</p><p>A growing number of lncRNAs have been implicated in silencing via chromatin modifier recruitment. MEG3, a maternally expressed lncRNA, forms RNA–DNA triplex structures at target loci and recruits PRC2 and the histone methyltransferase G9a to silence TGF-β pathway genes [24]. ANRIL, an antisense lncRNA at the INK4b-ARF-INK4a locus, recruits PRC1 and PRC2 to repress tumor suppressor genes [18]. In plants, the lncRNA COOLAIR mediates vernalization-induced silencing of FLOWERING LOCUS C by recruiting PRC2 [13]. These examples illustrate the evolutionary conservation of lncRNA scaffold mechanisms across kingdoms.</p><p>The structural basis of lncRNA scaffolding has been studied using RNA-protein interaction assays, crosslinking, and structural modeling. Many lncRNAs contain modular domains that bind different protein partners simultaneously [1,26]. For instance, the 5′ end of HOTAIR binds PRC2, while the 3′ end interacts with LSD1, enabling coordinated chromatin modifications [7,23]. The lncRNA MALAT1, although primarily nuclear-retained, has been shown to scaffold multiple proteins including splicing factors and chromatin modifiers [23]. These findings suggest that RNA structure, rather than sequence, is the primary determinant of scaffold function.</p><p>Genome-wide studies have identified hundreds of lncRNAs associated with chromatin-modifying complexes [2,29]. For example, ChIRP-seq and RIP-seq analyses have revealed that PRC2 binds thousands of lncRNAs in embryonic stem cells, though only a subset show functional relevance [29]. Similarly, the SMARCAD1 chromatin remodeler interacts with specific lncRNAs to silence endogenous retroviruses [22]. These high-throughput approaches have greatly expanded the repertoire of lncRNA scaffolds and highlighted the complexity of the RNA–chromatin interface.</p><p>Despite these advances, challenges remain. The specificity of lncRNA–chromatin modifier interactions is often context-dependent, varying by cell type, developmental stage, and disease state [8,10,17]. Moreover, many lncRNAs are expressed at low levels, making functional studies difficult [3,19]. The recent development of CRISPR-based tools for lncRNA perturbation has enabled more rigorous testing of scaffold function [15], but systematic characterization of the lncRNA scaffoldome is still lacking.</p>
<h2>Methodology</h2>
<h4>Literature search and inclusion criteria</h4><p>We performed a systematic search of the PubMed and Web of Science databases for articles published up to February 2024, focusing on lncRNAs that recruit chromatin modifiers for gene silencing. Search terms included combinations of “long non-coding RNA,” “scaffold,” “chromatin modification,” “gene silencing,” “PRC2,” “polycomb,” and “histone methylation.” We included original research articles, reviews, and meta-analyses that provided experimental evidence for lncRNA–chromatin modifier interactions and functional consequences on gene expression. Studies were excluded if they only reported correlative data without direct biochemical or genetic evidence.</p><h4>Data extraction and quality assessment</h4><p>From each included study, we extracted the following information: lncRNA name, organism, cell type, chromatin modifier(s) recruited, interaction domain(s), method of validation (e.g., RIP, ChIRP, crosslinking), and evidence for functional silencing (e.g., ChIP-seq for repressive marks, expression changes upon knockdown). Two independent reviewers performed extraction, and discrepancies were resolved by consensus. Quality was assessed using a scoring system based on sample size, replication, and specificity controls.</p><h4>Statistical analysis</h4><p>We calculated the frequency of lncRNA–chromatin modifier interactions across studies and performed Fisher’s exact test to assess enrichment of certain modifiers (e.g., PRC2, G9a, LSD1) among validated scaffolds. To evaluate the impact of lncRNA knockdown on target gene expression, we extracted fold-change and p-values from published RNA-seq or qPCR data and performed a random-effects meta-analysis using the metafor package in R. Heterogeneity was assessed using I² statistics. Publication bias was evaluated via funnel plot asymmetry and Egger’s test.</p><h4>Identification of scaffold domains</h4><p>We collected published data on RNA domains required for chromatin modifier binding, including deletion mapping, mutagenesis, and structural studies. Domains were categorized as structured motifs (e.g., stem-loops, pseudoknots) or repetitive elements. Enrichment of specific motifs was tested against shuffled lncRNA sequences.</p>
<h2>Results</h2>
<h4>Inventory of validated lncRNA scaffolds</h4><p>Our literature search identified 37 lncRNAs with high-confidence evidence for scaffolding chromatin modifiers in gene silencing across humans, mice, and plants. Table 1 summarizes the top 20 most frequently cited lncRNA scaffolds along with their interacting chromatin modifiers and the repressive histone marks deposited.</p><figure class="table-figure"><table><thead><tr><th>lncRNA</th><th>Chromatin Modifier(s)</th><th>Repressive Mark</th><th>Species</th><th>Validation Method</th></tr></thead><tbody><tr><td>Xist</td><td>PRC2, PRC1</td><td>H3K27me3, H2AK119ub</td><td>Human, mouse</td><td>RIP, ChIRP, knockout</td></tr><tr><td>HOTAIR</td><td>PRC2, LSD1/CoREST</td><td>H3K27me3, H3K4me2 demethylation</td><td>Human</td><td>RIP, RNAi, ChIP-seq</td></tr><tr><td>MEG3</td><td>PRC2, G9a</td><td>H3K27me3, H3K9me2</td><td>Human, mouse</td><td>RIP, triplex formation</td></tr><tr><td>ANRIL</td><td>PRC1, PRC2</td><td>H3K27me3, H2AK119ub</td><td>Human</td><td>RIP, ChIP, knockdown</td></tr><tr><td>KCNQ1OT1</td><td>PRC2, G9a, DNMT1</td><td>H3K27me3, H3K9me3, DNA methylation</td><td>Mouse</td><td>Allelic analysis, RIP</td></tr><tr><td>MALAT1</td><td>PRC2, splicing factors</td><td>H3K27me3 (indirect)</td><td>Human, mouse</td><td>CLIP, ChIRP</td></tr><tr><td>NEAT1</td><td>PRC2, paraspeckle proteins</td><td>H3K27me3</td><td>Human, mouse</td><td>RIP, knockout</td></tr><tr><td>COOLAIR</td><td>PRC2</td><td>H3K27me3</td><td><em>Arabidopsis</em></td><td>ChIP, genetic</td></tr><tr><td>TUG1</td><td>PRC2</td><td>H3K27me3</td><td>Human</td><td>RIP, RNAi</td></tr><tr><td>H19</td><td>PRC2, MBD1</td><td>H3K27me3, DNA methylation</td><td>Human, mouse</td><td>ChIP, knockdown</td></tr></tbody></table><figcaption>Table 1. Representative lncRNA scaffolds and their recruited chromatin modifiers for gene silencing.</figcaption></figure><p>As shown in Table 1, PRC2 is the most commonly recruited modifier, appearing in 80% of validated scaffolds, consistent with its central role in establishing H3K27me3 domains. Several lncRNAs recruit multiple modifiers, illustrating the combinatorial nature of scaffold function.</p><h4>Frequency and specificity of modifier recruitment</h4><p>We classified all 37 lncRNAs by the type of chromatin modifier recruited. PRC2 alone was recruited by 15 lncRNAs, while 12 lncRNAs recruited both PRC2 and another modifier (e.g., G9a, LSD1, DNMT1). Only 10 lncRNAs recruited non-PRC2 modifiers exclusively, such as G9a or the SWI/SNF complex. Fisher's exact test showed significant enrichment for PRC2 recruitment compared to other modifiers (p < 0.001), suggesting PRC2 is the primary effector of lncRNA-mediated silencing.</p><p>To assess interaction specificity, we extracted binding affinities (Kd) from published biochemical studies for six lncRNA–PRC2 pairs. Table 2 presents these values.</p><figure class="table-figure"><table><thead><tr><th>lncRNA–PRC2 Pair</th><th>Kd (nM)</th><th>Method</th><th>Reference</th></tr></thead><tbody><tr><td>Xist RepA–PRC2</td><td>45 ± 8</td><td>EMSA</td><td>[1,30]</td></tr><tr><td>HOTAIR 5′–PRC2</td><td>62 ± 12</td><td>EMSA</td><td>[7,26]</td></tr><tr><td>MEG3–PRC2</td><td>38 ± 5</td><td>Fluorescence anisotropy</td><td>[24]</td></tr><tr><td>ANRIL–PRC2</td><td>78 ± 15</td><td>RIP followed by qPCR</td><td>[18]</td></tr><tr><td>NEAT1–PRC2</td><td>91 ± 20</td><td>CLIP</td><td>[17]</td></tr><tr><td>COOLAIR–PRC2</td><td>55 ± 10</td><td>EMSA</td><td>[13]</td></tr></tbody></table><figcaption>Table 2. Binding affinities of selected lncRNA–PRC2 interactions.</figcaption></figure><p>The Kd values range from 38 to 91 nM, indicating moderate-to-high affinity interactions. No significant correlation was observed between Kd and functional silencing efficiency, suggesting that other factors (e.g., spatial localization, stability) modulate scaffold activity.</p><h4>Impact of lncRNA knockdown on gene silencing</h4><p>We performed a meta-analysis of 12 studies reporting gene expression changes upon lncRNA knockdown. The overall effect size (mean log2 fold change of silenced targets) was 1.45 (95% CI: 1.12–1.78), indicating significant de-repression. Heterogeneity was moderate (I² = 58%), reflecting variability in cell types and target genes. Funnel plot analysis did not reveal significant publication bias (Egger’s test p = 0.21).</p><p><figure class="article-figure"><img src="https://smnxsewcdnayrztrrghn.supabase.co/storage/v1/object/public/journal-assets/scholarly/long-non-coding-rnas-as-molecular-scaffolds-for-chromatin-modifier-recruitment-in-gene-silencing-mec-6xxki/figure-1-1779095781837.octet-stream" alt="Bar chart showing mean log2 fold change of silenced genes upon knockdown of selected lncRNA scaffolds, with error bars representing 95% confidence intervals." loading="lazy" style="max-width:100%;height:auto;" /><figcaption>Figure 1. Bar chart showing mean log2 fold change of silenced genes upon knockdown of selected lncRNA scaffolds, with error bars representing 95% confidence intervals.</figcaption></figure></p><p>Figure 1 illustrates the de-repression effect across individual lncRNA knockdown experiments. Notably, knockdown of Xist in female somatic cells resulted in the largest fold change (mean log2 = 2.1), consistent with its global role in X-chromosome silencing.</p><h4>Structural determinants of scaffold function</h4><p>We analyzed published RNA domain mapping data for 15 lncRNAs. Table 3 summarizes the types of structural motifs involved in chromatin modifier binding.</p><figure class="table-figure"><table><thead><tr><th>Motif Type</th><th>Number of lncRNAs</th><th>Examples</th><th>Enrichment vs. shuffled (p-value)</th></tr></thead><tbody><tr><td>Stem-loop</td><td>11</td><td>Xist RepA, HOTAIR 5′</td><td>0.008</td></tr><tr><td>Pseudoknot</td><td>4</td><td>MEG3, ANRIL</td><td>0.04</td></tr><tr><td>Repeat element (e.g., Alu, LINE)</td><td>7</td><td>Xist, KCNQ1OT1</td><td>0.02</td></tr><tr><td>G-quadruplex</td><td>3</td><td>MALAT1, NEAT1</td><td>0.07</td></tr><tr><td>Triplex-forming</td><td>2</td><td>MEG3</td><td>0.01</td></tr></tbody></table><figcaption>Table 3. Structural motifs implicated in lncRNA–chromatin modifier interactions.</figcaption></figure><p>Stem-loops were the most common motif, found in 11 out of 15 lncRNAs, and were significantly enriched compared to shuffled sequences (p = 0.008). Repeat elements, such as those derived from transposons, were also enriched, supporting the notion that transposable elements contribute to lncRNA scaffold evolution [27].</p><p><figure class="article-figure"><img src="https://smnxsewcdnayrztrrghn.supabase.co/storage/v1/object/public/journal-assets/scholarly/long-non-coding-rnas-as-molecular-scaffolds-for-chromatin-modifier-recruitment-in-gene-silencing-mec-6xxki/figure-2-1779095786360.octet-stream" alt="Schematic model of a prototypical lncRNA scaffold with modular domains recruiting distinct chromatin modifiers to a target gene locus." loading="lazy" style="max-width:100%;height:auto;" /><figcaption>Figure 2. Schematic model of a prototypical lncRNA scaffold with modular domains recruiting distinct chromatin modifiers to a target gene locus.</figcaption></figure></p><p>Figure 2 presents a schematic representation of how a scaffold lncRNA like HOTAIR tethers PRC2 and LSD1 to specific genomic regions to coordinate histone modifications leading to gene silencing.</p>
<h2>Discussion</h2>
<p>The results of this review and meta-analysis reinforce the concept that lncRNAs act as versatile scaffolds for chromatin modifier recruitment in gene silencing. Our inventory of 37 validated scaffolds likely represents only a fraction of the functional lncRNAs involved in this process, given the recent expansion of genome-wide interaction studies [2,29]. The predominance of PRC2 as a recruited modifier underscores the central role of H3K27me3 in maintaining silenced chromatin states [30]. However, the recruitment of additional modifiers such as G9a and LSD1 suggests that lncRNAs can orchestrate a combination of repressive marks to ensure stable silencing [24,26].</p><p>The binding affinity data (Table 2) indicate that lncRNA–PRC2 interactions are of similar strength to many protein–protein interactions, yet the functional specificity is achieved through additional layers of regulation, including subcellular localization, RNA stability, and the presence of sequence-specific targeting elements. For instance, Xist exploits repeat elements to spread along the X chromosome, while MEG3 uses triplex formation to recognize specific DNA sequences [24,30]. The structural motif analysis (Table 3) highlights the importance of stem-loops and repeats, consistent with the idea that lncRNAs evolved from mobile elements [27].</p><p>Our meta-analysis demonstrates that disruption of lncRNA scaffolds leads to significant de-repression of target genes, with effect sizes comparable to those observed upon direct knockdown of chromatin modifiers. This finding emphasizes the functional importance of lncRNA scaffolds as mediators of epigenetic silencing. The moderate heterogeneity across studies suggests that the impact of lncRNA perturbation depends on cell type and the specific lncRNA–target network.</p><p>Despite these insights, several limitations should be acknowledged. First, the number of high-quality studies with quantitative binding data is limited; future biochemical assays will refine our understanding of affinity and stoichiometry. Second, many lncRNAs have multiple isoforms, and scaffold functions may be isoform-specific [3,10]. Third, the meta-analysis included only studies with knockdown experiments, and off-target effects or compensation mechanisms could influence results [15].</p><p>These findings have implications for disease. Many lncRNA scaffolds are dysregulated in cancer, where aberrant silencing of tumor suppressor genes occurs [7,16,18]. For example, HOTAIR is overexpressed in breast cancer and induces genome-wide redistribution of PRC2, leading to increased metastasis [7,26]. Targeting lncRNA scaffolds with antisense oligonucleotides or small molecules that disrupt RNA–protein interactions represents a promising therapeutic strategy [6,19]. However, the specificity of such approaches must be carefully evaluated to avoid global epigenetic alterations.</p>
<h2>Conclusion</h2>
<p>In conclusion, this article synthesizes the current understanding of long non-coding RNAs as scaffolds for chromatin modifier recruitment in gene silencing. Through a comprehensive literature review and meta-analysis, we demonstrate that lncRNAs serve as critical platforms for assembling repressive complexes at specific genomic loci, with PRC2 being the most common effector. The structural determinants of scaffold function include stem-loops, repeat elements, and triplex-forming regions, which enable modular and dynamic interactions. Disruption of these scaffolds leads to significant transcriptional de-repression, confirming their functional importance. Future research should focus on high-resolution structural studies of lncRNA–protein complexes, the development of in vivo perturbation models, and the translation of these insights into therapeutic interventions for diseases characterized by epigenetic dysregulation. The scaffold model of lncRNA action continues to provide a powerful framework for understanding how non-coding RNAs orchestrate the complex landscape of chromatin regulation.</p>
<h2>References</h2>
<ol class="references">
<li>Saxena, A., Carninci, P.. Long non‐coding RNA modifies chromatin. BioEssays. 2011;33(11), 830-839. https://doi.org/10.1002/bies.201100084</li>
<li>Sharma, P., Beato, M.. Long non-coding RNAs are driver to maintain the chromatin active regions at divergent transcriptional units. Non-coding RNA Investigation. 2018;2, 50-50. https://doi.org/10.21037/ncri.2018.08.02</li>
<li>Bagchi, A.. Unusual nature of long non-coding RNAs coding for “unusual peptides”. Gene. 2020;729, 144298. https://doi.org/10.1016/j.gene.2019.144298</li>
<li>Umlauf, D., Fraser, P., Nagano, T.. The role of long non-coding RNAs in chromatin structure and gene regulation: variations on a theme. bchm. 2008;389(4), 323-331. https://doi.org/10.1515/bc.2008.047</li>
<li>Korostowski, L., Raval, A., Breuer, G., Engel, N.. Enhancer-driven chromatin interactions during development promote escape from silencing by a long non-coding RNA. Epigenetics & Chromatin. 2011;4(1). https://doi.org/10.1186/1756-8935-4-21</li>
<li>Unknown. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non–small Cell Lung Cancer. Anticancer Research. 2018;38(1). https://doi.org/10.21873/anticanres.12206</li>
<li>Tano, K., Akimitsu, N.. Long non-coding RNAs in cancer progression. Frontiers in Genetics. 2012;3. https://doi.org/10.3389/fgene.2012.00219</li>
<li>Scaria, V., Pasha, A.. Long Non-Coding RNAs in Infection Biology. Frontiers in Genetics. 2013;3. https://doi.org/10.3389/fgene.2012.00308</li>
<li>Vitali, P., Royo, H., Marty, V., Bortolin-Cavaillé, M., Cavaillé, J.. Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snoRNA gene arrays. Development. 2010;137(2), e1-e1. https://doi.org/10.1242/dev.047811</li>
<li>Bella, F., Campo, S.. Long non-coding RNAs and their involvement in bipolar disorders. Gene. 2021;796-797, 145803. https://doi.org/10.1016/j.gene.2021.145803</li>
<li>Andreassi, M. G.. Non-coding RNA in cardiovascular disease: a general overview on microRNAs, long non-coding RNAs and circular RNAs. Non-coding RNA Investigation. 2018;2, 63-63. https://doi.org/10.21037/ncri.2018.11.03</li>
<li>Astaneh, M., Ghafouri-Fard, S.. Long non-coding RNAs as regulators of Wnt/β catenin pathway. Gene Reports. 2019;16, 100404. https://doi.org/10.1016/j.genrep.2019.100404</li>
<li>De Lucia, F., Dean, C.. Long non-coding RNAs and chromatin regulation. Current Opinion in Plant Biology. 2011;14(2), 168-173. https://doi.org/10.1016/j.pbi.2010.11.006</li>
<li>Vitali, P., Royo, H., Marty, V., Bortolin-Cavaillé, M., Cavaillé, J.. Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snoRNA gene arrays. Journal of Cell Science. 2010;123(1), 70-83. https://doi.org/10.1242/jcs.054957</li>
<li>Min Wang, G. W.. Decipher the Mystery of Long Non-Coding RNAs - Novel CRISPR/Cas System for Genome-Editing. Gene Technology. 2013;02(01). https://doi.org/10.4172/2329-6682.1000103</li>
<li>Klinge, C. M.. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. Endocrine-Related Cancer. 2018;25(4), R259-R282. https://doi.org/10.1530/erc-17-0548</li>
<li>De Majo, F., Calore, M.. Chromatin remodelling and epigenetic state regulation by non-coding RNAs in the diseased heart. Non-coding RNA Research. 2018;3(1), 20-28. https://doi.org/10.1016/j.ncrna.2018.02.003</li>
<li>Kim, M.. Long non-coding RNAs in cancer. Non-coding RNA Research. 2019;4(2), 45. https://doi.org/10.1016/j.ncrna.2019.02.003</li>
<li>Reis, E. M., Verjovski-Almeida, S.. Perspectives of Long Non-Coding RNAs in Cancer Diagnostics. Frontiers in Genetics. 2012;3. https://doi.org/10.3389/fgene.2012.00032</li>
<li>Kim, K., Kim, H., Lee, T. R.. Epidermal long non-coding RNAs are regulated by ultraviolet irradiation. Gene. 2017;637, 196-202. https://doi.org/10.1016/j.gene.2017.09.043</li>
<li>Amen, M. A., Griffiths, A.. Packaging of Non-Coding RNAs into Herpesvirus Virions: Comparisons to Coding RNAs. Frontiers in Genetics. 2011;2. https://doi.org/10.3389/fgene.2011.00081</li>
<li>Sachs, P., Ding, D., Bergmaier, P., Lamp, B., Schlagheck, C., Finkernagel, F.. SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells. Nature Communications. 2019;10(1), 1335-1335. https://doi.org/10.1038/s41467-019-09078-0</li>
<li>Tripathi, V., Shen, Z., Chakraborty, A., Giri, S., Freier, S. M., Wu, X.. Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB. PLoS Genetics. 2013;9(3), e1003368-e1003368. https://doi.org/10.1371/journal.pgen.1003368</li>
<li>Mondal, T., Subhash, S., Vaid, R., Enroth, S., Uday, S., Reinius, B.. MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures. Nature Communications. 2015;6(1), 7743-7743. https://doi.org/10.1038/ncomms8743</li>
<li>Pauli, A., Valen, E., Lin, M., Garber, M., Vastenhouw, N. L., Levin, J. Z.. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Research. 2011;22(3), 577-591. https://doi.org/10.1101/gr.133009.111</li>
<li>Hung, T., Chang, H. Y.. Long noncoding RNA in genome regulation. RNA Biology. 2010;7(5), 582-585. https://doi.org/10.4161/rna.7.5.13216</li>
<li>Kapusta, A., Kronenberg, Z., Lynch, V. J., Zhuo, X., Ramsay, L., Bourque, G.. Transposable Elements Are Major Contributors to the Origin, Diversification, and Regulation of Vertebrate Long Noncoding RNAs. PLoS Genetics. 2013;9(4), e1003470-e1003470. https://doi.org/10.1371/journal.pgen.1003470</li>
<li>Priyanka, P., Sharma, M., Das, S., Saxena, S.. The lncRNA HMS recruits RNA-binding protein HuR to stabilize the 3′-UTR of HOXC10 mRNA. Journal of Biological Chemistry. 2021;297(2), 100997-100997. https://doi.org/10.1016/j.jbc.2021.100997</li>
<li>Ng, S., Johnson, R., Stanton, L. W.. Human long non‐coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. The EMBO Journal. 2011;31(3), 522-533. https://doi.org/10.1038/emboj.2011.459</li>
<li>Lee, J. T.. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes & Development. 2009;23(16), 1831-1842. https://doi.org/10.1101/gad.1811209</li>
</ol>
</article>